.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer last year for an i...
.On the heels of a phase 3 gain that fell short to excite real estate investors, Ironwood Pharmaceut...
.Do not stop Monte Rosa Therapies currently. The Boston-based biotech is enjoying after authorizing ...
.Welcome to recently's Chutes & Ladders, our summary of significant leadership hirings, firings a...
.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang ...
.AbbVie has gone back to the source of its antipsychotic goliath Vraylar trying to find another runa...
.GenSight Biologics is actually full weeks away from running out of amount of money. Again. The biot...
.Monopar Therapies is actually recovering a medication coming from the dump of AstraZeneca's rare di...
.With brand new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of profession...
.After creating a gene therapy collaboration with Dyno Rehabs in 2020, Roche is actually back for ev...